Director, New Product Planning & BD Support

Overview:\n\nWe are seeking a strategic, forward-thinking leader to join our team in a newly created role that is accountable for conducting assessment of both internal and external asset opportunities. This individual will be accountable to integrate deep market insight, competitive intelligence, clinical understanding, and patient-centric thinking to inform development strategies and maximize global impact. This individual will also support our BD team in evaluating external opportunities as Alnylam looks to supplement internal innovation with external opportunities. This role will report to the VP of Early Commercial Strategy.\n\nThe ideal candidate thrives at the intersection of science and strategy, brings a strong track record of cross-functional engagement, and is energized by the opportunity to help build innovative medicines from early development through launch readiness. The candidate is required to have strong interpersonal skills as this role will work with a variety of stakeholders across all levels of the organization. \n\nKey Responsibilities:\n\n * Market Research \u0026 Analysis: Conduct in-depth research on market trends, competitor activity, and potential new business segments to identify growth opportunities. Inform the development of forecast assumptions for financial models.\n * Formulate early commercial strategy and approach for select pipeline programs; Develop target product profiles, serve as commercial voice for the asset in key governance forums.\n * Provide commercial input and strategic guidance to program teams to inform key business decisions on early-stage clinical programs.\n * Collaborate cross-functionally to conduct rigorous market assessments on key disease areas to inform preclinical strategic planning.\n * Understand and communicate requirements for reimbursement and differentiation to ensure successful global commercialization of pipeline assets.\n * Identify gaps in internal understanding of target diseases and create detailed plans to address gaps through KOL engagement and primary market research.\n\n\n\nQualifications:\n\n * Bachelor\u2019s Degree in Life Sciences or equivalent required, MBA preferred\n * Minimum 8 years\u2019 experience inclusive of market analytics, new product planning and global brand marketing\n * Ability to navigate across multiple disease areas. Experience in CNS, Cardiovascular, Hematology, or Metabolic therapeutic areas preferred\n * Demonstrated experience collaborating cross-functionally and influencing program development teams.\n * Strong understanding of pharmaceutical development path and ability to identify operational choices that could impact commercialization.\n * Ability to synthesize insights multiple data sources (e.g. primary and secondary market research and data) and translate into strong, well-supported recommendations.\n * Strong analytical and forecasting capabilities.\n * Aptitude for understanding scientific concepts related to research and development.\n * Excellent communication and presentation skills, both written and oral.\n\n\n\nU.S. Pay Range\n\n$208,300.00 - $281,800.00\n\nThe pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).\n\nAlnylam\u2019s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.\n\nLearn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers\n\nAbout Alnylam\n\nWe are the leader in RNAi therapeutics \u2013 a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what\u2019s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We\u0027re proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.\n\nAt Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.\n